Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States

由 Ross, Lisa L., Shortino, Denise, Shaefer, Mark S.
發表在 AIDS Res Hum Retroviruses (2018)

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57...

由 Small, Catherine Butkus, Margolis, David A., Shaefer, Mark S., Ross, Lisa L.
發表在 BMC Infect Dis (2017)

Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudi...

由 Robertson, Kevin, Maruff, Paul, Ross, Lisa L., Wohl, David, Small, Catherine B, Edelstein, Howard, Shaefer, Mark S.
發表在 J Neurovirol (2018)

Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data from Clinical Trials

由 Nan, Cassandra, Shaefer, Mark S, Urbaityte, Rimgaile, Oyee, James, Hopking, Judy, Ragone, Leigh, McCoig, Cynthia, Vannappagari, Vani
發表在 Open Forum Infect Dis (2017)

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice...

由 Kumar, Princy N, Salvato, Patricia, LaMarca, Anthony, DeJesus, Edwin, Patel, Parul, McClernon, Daniel, Florance, Allison, Shaefer, Mark S
出版 2009

Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open‐Label, Randomized Study

由 Adkison, Kimberly, Wolstenholme, Allen, Lou, Yu, Zhang, Zhiping, Eld, Amy, Perger, Teodora, Vangerow, Harald, Hayward, Katy, Shaefer, Mark, McCoig, Cynthia
發表在 Clin Pharmacol Ther (2017)

Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials

由 Nan, Cassandra, Shaefer, Mark, Urbaityte, Rimgaile, Oyee, James, Hopking, Judy, Ragone, Leigh, Perger, Teodora, Win, Beta, Vangerow, Harald, McCoig, Cynthia, Vannappagari, Vani
發表在 Open Forum Infect Dis (2018)

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA(®) observational database: a cohort study

由 Mounzer, Karam, Hsu, Ricky, Fusco, Jennifer S., Brunet, Laurence, Henegar, Cassidy E., Vannappagari, Vani, Stainsby, Chris M., Shaefer, Mark S., Ragone, Leigh, Fusco, Gregory P.
發表在 AIDS Res Ther (2019)

Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks

由 Squires, Kathleen E, Young, Benjamin, Santiago, Lizette, Dretler, Robin H, Walmsley, Sharon L, Zhao, Henry H, Pakes, Gary E, Ross, Lisa L, Shaefer, Mark S
發表在 HIV AIDS (Auckl) (2017)

Inflammatory Biomarker Changes and Their Correlation with Framingham Cardiovascular Risk and Lipid Changes in Antiretroviral-Naive HIV-Infected Patients Treated for 144 Weeks with...

由 Young, Benjamin, Squires, Kathleen E., Ross, Lisa L., Santiago, Lizette, Sloan, Louis M., Zhao, Henry H., Wine, Brian C., Pakes, Gary E., Margolis, David A., Shaefer, Mark S.
出版 2013

Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial

由 Wohl, David A., Bhatti, Laveeza, Small, Catherine B., Edelstein, Howard, Zhao, Henry H., Margolis, David A., DeJesus, Edwin, Weinberg, Winkler G., Ross, Lisa L., Shaefer, Mark S.
出版 2014

HIV-1 Transmission Patterns in Antiretroviral Therapy-Naïve, HIV-Infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-Deep DNA Sequencing

由 Ross, Lisa L., Horton, Joseph, Hasan, Samiul, Brown, James R., Murphy, Daniel, DeJesus, Edwin, Potter, Martin, LaMarca, Anthony, Melendez-Rivera, Ivan, Ward, Douglas, Uy, Jonathon, Shaefer, Mark S.
出版 2014

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure

由 Stainsby, Chris M., Perger, Teodora M., Vannappagari, Vani, Mounzer, Karam C., Hsu, Ricky K., Henegar, Cassidy E., Oyee, James, Urbaityte, Rimgaile, Lane, Charlotte E., Carter, Lindsay M., Pakes, Gary E., Shaefer, Mark S.
發表在 Pharmacotherapy (2018)

884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies

由 Teichner, Paula, Cutrell, Amy, D’Amico, Ronald, Dorey, David, Griffith, Sandy, Harrington, Conn M, Huang, Jenny, Hudson, Krischan J, Margolis, David, Mrus, Joseph, Polli, Joseph, Spreen, William, Williams, Peter, Van Solingen-Ristea, Rodica, Shaefer, Mark S
發表在 Open Forum Infect Dis (2019)

2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preference...

由 Mantsios, Andrea R, Murray, Miranda, Karver, Tahilin Sanchez, Davis, Wendy, Margolis, David, Kumar, Princy, Swindells, Susan, Bredeek, Fritz, Deltoro, Miguel García, García, Rafael Rubio, Antela, Antonio, Garris, Cindy, Shaefer, Mark S, Gomis, Santiago Cenoz, Bernaldez, Miguel Pascual, Kerrigan, Deanna
發表在 Open Forum Infect Dis (2019)

Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

由 Murray, Miranda, Antela, Antonio, Mills, Anthony, Huang, Jenny, Jäger, Hans, Bernal, Enrique, Lombaard, Johan, Katner, Harold, Walmsley, Sharon, Khuong-Josses, Marie-Aude, Hudson, Krischan, Dorey, David, Griffith, Sandy, Spreen, William, Vanveggel, Simon, Shaefer, Mark, Margolis, David, Chounta, Vasiliki
發表在 AIDS Behav (2020)

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretro...

由 Ross, Lisa L., Walker, A. Sarah, Lou, Yu, Tenorio, Allan R., Gibb, Diana M., Double, Julia, Gilks, Charles, McCoig, Cynthia C., Munderi, Paula, Musoro, Godfrey, Kityo, Cissy M., Grosskurth, Heiner, Hakim, James, Mugyenyi, Peter N., Cutrell, Amy, Perger, Teodora, Shaefer, Mark S.
發表在 PLoS One (2019)

New Genetic Predictors for Abacavir Tolerance in HLA-B*57:01 Positive Individuals

由 PAVLOS, Rebecca, DESHPANDE, Pooja, CHOPRA, Abha, LEARY, Shay, STRAUTINS, Kaija, NOLAN, David, THORBORN, Daren, SHAEFER, Mark, RAUCH, Andri, DUNN, David, MONTANER, Julio, RACHLIS, Anita, ALMEIDA, Coral-Ann, CHOO, Linda, JAMES, Ian, REDWOOD, Alec J., LI, Yueran, GAUDIERI, Silvana, MALLAL, Simon A., PHILLIPS, Elizabeth J.
發表在 Hum Immunol (2020)